APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Polio Vaccines (OPV)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Polio Vaccines (OPV) Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchOral Polio Vaccines (OPV) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Polio Vaccines (OPV) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Oral Polio Vaccines (OPV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Polio Vaccines (OPV) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Polio Vaccines (OPV) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Oral Polio Vaccines (OPV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Polio Vaccines (OPV) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Polio Vaccines (OPV) market include Sanofi, GSK, Tiantan Biological, Serum Institute, Panacea Biotec Ltd, IMBCA, Halfkin Bio-Pharmaceuticals, Bio-Med and Bibcol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Polio Vaccines (OPV) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Polio Vaccines (OPV) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Polio Vaccines (OPV) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Polio Vaccines (OPV) market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Polio Vaccines (OPV) Segment by Company

Sanofi

GSK

Tiantan Biological

Serum Institute

Panacea Biotec Ltd

IMBCA

Halfkin Bio-Pharmaceuticals

Bio-Med

Bibcol

Oral Polio Vaccines (OPV) Segment by Type

Trivalent OPV

Bivalent OPV

Oral Polio Vaccines (OPV) Segment by Application

Public

Private

Oral Polio Vaccines (OPV) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral Polio Vaccines (OPV) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Polio Vaccines (OPV) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Polio Vaccines (OPV) significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Polio Vaccines (OPV) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Polio Vaccines (OPV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Polio Vaccines (OPV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Polio Vaccines (OPV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Polio Vaccines (OPV) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Polio Vaccines (OPV) industry.

Chapter 3: Detailed analysis of Oral Polio Vaccines (OPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Polio Vaccines (OPV) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Polio Vaccines (OPV) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Polio Vaccines (OPV) Industry Trends Table 2. Oral Polio Vaccines (OPV) Industry Drivers Table 3. Oral Polio Vaccines (OPV) Industry Opportunities and Challenges Table 4. Oral Polio Vaccines (OPV) Industry Restraints Table 5. Global Oral Polio Vaccines (OPV) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Polio Vaccines (OPV) Revenue Share by Company (2021-2026) Table 7. Global Oral Polio Vaccines (OPV) Sales Volume by Company (k doses) & (2021-2026) Table 8. Global Oral Polio Vaccines (OPV) Sales Volume Share by Company (2021-2026) Table 9. Global Oral Polio Vaccines (OPV) Average Price (US$/dose) of Company (2021-2026) Table 10. Global Oral Polio Vaccines (OPV) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Polio Vaccines (OPV) Key Company Manufacturing Base & Headquarters Table 12. Global Oral Polio Vaccines (OPV) Company, Product Type & Application Table 13. Global Oral Polio Vaccines (OPV) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Trivalent OPV Table 18. Significant Companies of Bivalent OPV Table 19. Global Oral Polio Vaccines (OPV) Sales Volume by Type 2021 VS 2025 VS 2032 (k doses) Table 20. Global Oral Polio Vaccines (OPV) Sales Volume by Type (2021-2026) & (k doses) Table 21. Global Oral Polio Vaccines (OPV) Sales Volume by Type (2027-2032) & (k doses) Table 22. Global Oral Polio Vaccines (OPV) Sales Volume Share by Type (2021-2026) Table 23. Global Oral Polio Vaccines (OPV) Sales Volume Share by Type (2027-2032) Table 24. Global Oral Polio Vaccines (OPV) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Polio Vaccines (OPV) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oral Polio Vaccines (OPV) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oral Polio Vaccines (OPV) Sales Value Share by Type (2021-2026) Table 28. Global Oral Polio Vaccines (OPV) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Public Table 30. Significant Companies of Private Table 31. Global Oral Polio Vaccines (OPV) Sales Volume by Application 2021 VS 2025 VS 2032 (k doses) Table 32. Global Oral Polio Vaccines (OPV) Sales Volume by Application (2021-2026) & (k doses) Table 33. Global Oral Polio Vaccines (OPV) Sales Volume by Application (2027-2032) & (k doses) Table 34. Global Oral Polio Vaccines (OPV) Sales Volume Share by Application (2021-2026) Table 35. Global Oral Polio Vaccines (OPV) Sales Volume Share by Application (2027-2032) Table 36. Global Oral Polio Vaccines (OPV) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oral Polio Vaccines (OPV) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Oral Polio Vaccines (OPV) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Oral Polio Vaccines (OPV) Sales Value Share by Application (2021-2026) Table 40. Global Oral Polio Vaccines (OPV) Sales Value Share by Application (2027-2032) Table 41. Global Oral Polio Vaccines (OPV) Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 42. Global Oral Polio Vaccines (OPV) Sales by Region (2021-2026) & (k doses) Table 43. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2021-2026) Table 44. Global Oral Polio Vaccines (OPV) Sales by Region (2027-2032) & (k doses) Table 45. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2027-2032) Table 46. Global Oral Polio Vaccines (OPV) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Polio Vaccines (OPV) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Oral Polio Vaccines (OPV) Sales Value Share by Region (2021-2026) Table 49. Global Oral Polio Vaccines (OPV) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Oral Polio Vaccines (OPV) Sales Value Share by Region (2027-2032) Table 51. Global Oral Polio Vaccines (OPV) Market Average Price (US$/dose) by Region (2021-2026) Table 52. Global Oral Polio Vaccines (OPV) Market Average Price (US$/dose) by Region (2027-2032) Table 53. Global Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Table 54. Global Oral Polio Vaccines (OPV) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 56. Global Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 57. Global Oral Polio Vaccines (OPV) Sales by Country (2027-2032) & (k doses) Table 58. Global Oral Polio Vaccines (OPV) Sales Market Share by Country (2027-2032) Table 59. Global Oral Polio Vaccines (OPV) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Oral Polio Vaccines (OPV) Sales Value Market Share by Country (2021-2026) Table 61. Global Oral Polio Vaccines (OPV) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Oral Polio Vaccines (OPV) Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 66. Sanofi Oral Polio Vaccines (OPV) Product Portfolio Table 67. Sanofi Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 71. GSK Oral Polio Vaccines (OPV) Product Portfolio Table 72. GSK Recent Development Table 73. Tiantan Biological Company Information Table 74. Tiantan Biological Business Overview Table 75. Tiantan Biological Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 76. Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio Table 77. Tiantan Biological Recent Development Table 78. Serum Institute Company Information Table 79. Serum Institute Business Overview Table 80. Serum Institute Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 81. Serum Institute Oral Polio Vaccines (OPV) Product Portfolio Table 82. Serum Institute Recent Development Table 83. Panacea Biotec Ltd Company Information Table 84. Panacea Biotec Ltd Business Overview Table 85. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 86. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio Table 87. Panacea Biotec Ltd Recent Development Table 88. IMBCA Company Information Table 89. IMBCA Business Overview Table 90. IMBCA Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 91. IMBCA Oral Polio Vaccines (OPV) Product Portfolio Table 92. IMBCA Recent Development Table 93. Halfkin Bio-Pharmaceuticals Company Information Table 94. Halfkin Bio-Pharmaceuticals Business Overview Table 95. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 96. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio Table 97. Halfkin Bio-Pharmaceuticals Recent Development Table 98. Bio-Med Company Information Table 99. Bio-Med Business Overview Table 100. Bio-Med Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 101. Bio-Med Oral Polio Vaccines (OPV) Product Portfolio Table 102. Bio-Med Recent Development Table 103. Bibcol Company Information Table 104. Bibcol Business Overview Table 105. Bibcol Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 106. Bibcol Oral Polio Vaccines (OPV) Product Portfolio Table 107. Bibcol Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Oral Polio Vaccines (OPV) Distributors List Table 111. Oral Polio Vaccines (OPV) Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Oral Polio Vaccines (OPV) Product Image Figure 2. Global Oral Polio Vaccines (OPV) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Polio Vaccines (OPV) Sales (2021-2032) & (k doses) Figure 5. Global Oral Polio Vaccines (OPV) Sales Average Price (US$/dose) & (2021-2032) Figure 6. Global Oral Polio Vaccines (OPV) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Trivalent OPV Image Figure 10. Bivalent OPV Image Figure 11. Global Oral Polio Vaccines (OPV) Sales Volume by Type (2021 VS 2025 VS 2032) & (k doses) Figure 12. Global Oral Polio Vaccines (OPV) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Polio Vaccines (OPV) Sales Volume Share by Type (2021-2032) Figure 14. Global Oral Polio Vaccines (OPV) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral Polio Vaccines (OPV) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Polio Vaccines (OPV) Sales Value Share by Type (2021-2032) Figure 17. Public Image Figure 18. Private Image Figure 19. Global Oral Polio Vaccines (OPV) Sales Volume by Application (2021 VS 2025 VS 2032) & (k doses) Figure 20. Global Oral Polio Vaccines (OPV) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Oral Polio Vaccines (OPV) Sales Volume Share by Application (2021-2032) Figure 22. Global Oral Polio Vaccines (OPV) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oral Polio Vaccines (OPV) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Oral Polio Vaccines (OPV) Sales Value Share by Application (2021-2032) Figure 25. Global Oral Polio Vaccines (OPV) Sales by Region: 2021 VS 2025 VS 2032 (k doses) Figure 26. Global Oral Polio Vaccines (OPV) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Oral Polio Vaccines (OPV) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Oral Polio Vaccines (OPV) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Oral Polio Vaccines (OPV) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Oral Polio Vaccines (OPV) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Oral Polio Vaccines (OPV) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Oral Polio Vaccines (OPV) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Oral Polio Vaccines (OPV) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Oral Polio Vaccines (OPV) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Oral Polio Vaccines (OPV) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Oral Polio Vaccines (OPV) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent OPV
  • Bivalent OPV
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Tiantan Biological
  • Serum Institute
  • Panacea Biotec Ltd
  • IMBCA
  • Halfkin Bio-Pharmaceuticals
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  4. 1.2.2 Global Oral Polio Vaccines (OPV) Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Polio Vaccines (OPV) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Polio Vaccines (OPV) Market Dynamics
  1. 2.1 Oral Polio Vaccines (OPV) Industry Trends
  2. 2.2 Oral Polio Vaccines (OPV) Industry Drivers
  3. 2.3 Oral Polio Vaccines (OPV) Industry Opportunities and Challenges
  4. 2.4 Oral Polio Vaccines (OPV) Industry Restraints
3 Oral Polio Vaccines (OPV) Market by Company
  1. 3.1 Global Oral Polio Vaccines (OPV) Company Revenue Ranking in 2025
  2. 3.2 Global Oral Polio Vaccines (OPV) Revenue by Company (2021-2026)
  3. 3.3 Global Oral Polio Vaccines (OPV) Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Polio Vaccines (OPV) Average Price by Company (2021-2026)
  5. 3.5 Global Oral Polio Vaccines (OPV) Company Ranking (2024-2026)
  6. 3.6 Global Oral Polio Vaccines (OPV) Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Polio Vaccines (OPV) Company Product Type and Application
  8. 3.8 Global Oral Polio Vaccines (OPV) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Polio Vaccines (OPV) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Polio Vaccines (OPV) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Polio Vaccines (OPV) Market by Type
  1. 4.1 Oral Polio Vaccines (OPV) Type Introduction
  2. 4.1.1 Trivalent OPV
  3. 4.1.2 Bivalent OPV
  4. 4.2 Global Oral Polio Vaccines (OPV) Sales Volume by Type
  5. 4.2.1 Global Oral Polio Vaccines (OPV) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Polio Vaccines (OPV) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oral Polio Vaccines (OPV) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oral Polio Vaccines (OPV) Sales Value by Type
  9. 4.3.1 Global Oral Polio Vaccines (OPV) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Polio Vaccines (OPV) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oral Polio Vaccines (OPV) Sales Value Share by Type (2021-2032)
5 Oral Polio Vaccines (OPV) Market by Application
  1. 5.1 Oral Polio Vaccines (OPV) Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Polio Vaccines (OPV) Sales Volume by Application
  5. 5.2.1 Global Oral Polio Vaccines (OPV) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Polio Vaccines (OPV) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oral Polio Vaccines (OPV) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oral Polio Vaccines (OPV) Sales Value by Application
  9. 5.3.1 Global Oral Polio Vaccines (OPV) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Polio Vaccines (OPV) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oral Polio Vaccines (OPV) Sales Value Share by Application (2021-2032)
6 Oral Polio Vaccines (OPV) Regional Sales and Value Analysis
  1. 6.1 Global Oral Polio Vaccines (OPV) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Polio Vaccines (OPV) Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Polio Vaccines (OPV) Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Polio Vaccines (OPV) Sales by Region (2027-2032)
  5. 6.3 Global Oral Polio Vaccines (OPV) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Polio Vaccines (OPV) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Polio Vaccines (OPV) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Polio Vaccines (OPV) Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Polio Vaccines (OPV) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  12. 6.6.2 North America Oral Polio Vaccines (OPV) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Polio Vaccines (OPV) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Polio Vaccines (OPV) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  21. 6.9.2 South America Oral Polio Vaccines (OPV) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Polio Vaccines (OPV) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Polio Vaccines (OPV) Sales Value Share by Country, 2025 VS 2032
7 Oral Polio Vaccines (OPV) Country-level Sales and Value Analysis
  1. 7.1 Global Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Polio Vaccines (OPV) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Polio Vaccines (OPV) Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Polio Vaccines (OPV) Sales by Country (2027-2032)
  6. 7.4 Global Oral Polio Vaccines (OPV) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Polio Vaccines (OPV) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Polio Vaccines (OPV) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Polio Vaccines (OPV) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Polio Vaccines (OPV) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Polio Vaccines (OPV) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Tiantan Biological
  14. 8.3.1 Tiantan Biological Company Information
  15. 8.3.2 Tiantan Biological Business Overview
  16. 8.3.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio
  18. 8.3.5 Tiantan Biological Recent Developments
  19. 8.4 Serum Institute
  20. 8.4.1 Serum Institute Company Information
  21. 8.4.2 Serum Institute Business Overview
  22. 8.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio
  24. 8.4.5 Serum Institute Recent Developments
  25. 8.5 Panacea Biotec Ltd
  26. 8.5.1 Panacea Biotec Ltd Company Information
  27. 8.5.2 Panacea Biotec Ltd Business Overview
  28. 8.5.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio
  30. 8.5.5 Panacea Biotec Ltd Recent Developments
  31. 8.6 IMBCA
  32. 8.6.1 IMBCA Company Information
  33. 8.6.2 IMBCA Business Overview
  34. 8.6.3 IMBCA Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 IMBCA Oral Polio Vaccines (OPV) Product Portfolio
  36. 8.6.5 IMBCA Recent Developments
  37. 8.7 Halfkin Bio-Pharmaceuticals
  38. 8.7.1 Halfkin Bio-Pharmaceuticals Company Information
  39. 8.7.2 Halfkin Bio-Pharmaceuticals Business Overview
  40. 8.7.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio
  42. 8.7.5 Halfkin Bio-Pharmaceuticals Recent Developments
  43. 8.8 Bio-Med
  44. 8.8.1 Bio-Med Company Information
  45. 8.8.2 Bio-Med Business Overview
  46. 8.8.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio
  48. 8.8.5 Bio-Med Recent Developments
  49. 8.9 Bibcol
  50. 8.9.1 Bibcol Company Information
  51. 8.9.2 Bibcol Business Overview
  52. 8.9.3 Bibcol Oral Polio Vaccines (OPV) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio
  54. 8.9.5 Bibcol Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Polio Vaccines (OPV) Value Chain Analysis
  2. 9.1.1 Oral Polio Vaccines (OPV) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Polio Vaccines (OPV) Sales Mode & Process
  6. 9.2 Oral Polio Vaccines (OPV) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Polio Vaccines (OPV) Distributors
  9. 9.2.3 Oral Polio Vaccines (OPV) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst